Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
Capodanno D, Collet JP, Dangas G, Montalescot G, Ten Berg JM, Windecker S, Angiolillo DJ. Capodanno D, et al. Among authors: angiolillo dj. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1688-1703. doi: 10.1016/j.jcin.2021.06.020. JACC Cardiovasc Interv. 2021. PMID: 34353601 Free article. Review.
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Lotrionte M, Biondi-Zoccai GG, Agostoni P, Abbate A, Angiolillo DJ, Valgimigli M, Moretti C, Meliga E, Cuisset T, Alessi MC, Montalescot G, Collet JP, Di Sciascio G, Waksman R, Testa L, Sangiorgi G, Laudito A, Trevi GP, Sheiban I. Lotrionte M, et al. Among authors: angiolillo dj. Am J Cardiol. 2007 Oct 15;100(8):1199-206. doi: 10.1016/j.amjcard.2007.05.048. Epub 2007 Jul 30. Am J Cardiol. 2007. PMID: 17920357 Review.
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E; PRINCIPLE-TIMI 44 Investigators. Wiviott SD, et al. Among authors: angiolillo dj. Circulation. 2007 Dec 18;116(25):2923-32. doi: 10.1161/CIRCULATIONAHA.107.740324. Epub 2007 Dec 3. Circulation. 2007. PMID: 18056526 Clinical Trial.
ADP receptor antagonism: what's in the pipeline?
Angiolillo DJ. Angiolillo DJ. Am J Cardiovasc Drugs. 2007;7(6):423-32. doi: 10.2165/00129784-200707060-00005. Am J Cardiovasc Drugs. 2007. PMID: 18076209 Review.
Contemporary issues on clopidogrel therapy: a critical appraisal.
Capodanno D, Angiolillo DJ. Capodanno D, et al. Among authors: angiolillo dj. Intern Emerg Med. 2009 Jun;4(3):195-8. doi: 10.1007/s11739-009-0241-8. Epub 2009 Mar 31. Intern Emerg Med. 2009. PMID: 19333714 No abstract available.
Platelet thrombin receptor antagonism and atherothrombosis.
Angiolillo DJ, Capodanno D, Goto S. Angiolillo DJ, et al. Eur Heart J. 2010 Jan;31(1):17-28. doi: 10.1093/eurheartj/ehp504. Epub 2009 Nov 30. Eur Heart J. 2010. PMID: 19948715 Free PMC article. Review.
735 results